Ameliorative Potential of Mesenchymal Stem Cells and Hematopoietic Stem Cells against CCl4 Induced Chromosomal Abnormalities in Experimental Rat Liver Fibrosis


Background and Objective: The liver is responsible for metabolism and detoxification of the most of components that enter the body. Once the liver became injured, its efficient treatment with famous chemical drugs was limited. Therefore, interest concerned the use of alternative medicines for the treatment of hepatic disease has been arisen. The present study was aimed to investigate the therapeutic effect of the two types of stem cells against chromosomal aberrations in bone marrow (BM) cells of rats treated with carbon tetrachloride (CCl4). Design and Method: BM-derived mesenchymal stem cells (MSCs) were isolated and propagated in culture for 2 weeks and were characterized morphologically. Human umbilical cord blood (UCB) cells were obtained after full-term caesarean delivery from healthy donors. Low-density mononuclear cells were separated over Ficoll-Paque, and CD34+ hematopoietic cells were isolated using a magnetic cell sorter. Rats were divided into 4 groups: control, CCl4, CCl4 plus MSC, and CCl4 plus CD34+. Liver tissue was examined histopathologically for all groups. Results: The results of the present study indicated a significant increase (p 0.05) in the number of metaphases with different types of chromosomal aberrations in CCl4 group. Treatment of the animals with BM-MSCs and UCB-CD34+ cells improved both genotoxicity and histopathological changes induced by CCl4.

Share and Cite:

Ahmed, R. , Roshdy, N. , Saleh, H. , Aref, M. , Hassan, N. and Mohammed, N. (2014) Ameliorative Potential of Mesenchymal Stem Cells and Hematopoietic Stem Cells against CCl4 Induced Chromosomal Abnormalities in Experimental Rat Liver Fibrosis. Stem Cell Discovery, 4, 90-98. doi: 10.4236/scd.2014.44010.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Giannandrea, M. and Parks, W.C. (2014) Diverse Functions of Matrix Metalloproteinases during Fibrosis. Disease Models and Mechanisms, 7, 193-203.
[2] Brent, J.A. and Rumack, B.H. (1993) Role of Free Radicals in Toxic Hepatic Injury II: Free Radical Biochemistry. Clinical Toxicology, 31, 173-196.
[3] Brautbar, N. and Williams, J. (2002) Industrial Solvents and Liver Toxicity: Risk Assessment, Risk Factors and Mechanisms. International Journal of Hygiene and Environmental Health, 205, 479-491.
[4] Green, M.H.L. (1978) Mechanisms of Bacterial Mutagenesis and Properties of Mutagenesis Tester Strains. Archives of Toxicology, 39, 241.
[5] Ueyama, H., Horibe, T., Hinotsu, S., Tanaka, T. and Kawakami, K. (2012) Chromosomal Variability of Human Mesenchymal Stem Cells Cultured under Hypoxic Conditions. Journal of Cellular and Molecular Medicine, 16, 72-82.
[6] Maitra, A., Arking, D.E. and Shivapurkar, N. (2005) Genomic Alterations in Cultured Human Embryonic Stem Cells. Nature Genetics, 37, 1099-1103.
[7] Rosland, G.V., Svendsen, A. and Torsvik, A. (2009) Long-Term Cultures of Bone Marrow Derived Human Mesenchumal Stem Cells Frequently Undergo Spontaneous Malignant Transformation. Cancer Research, 69, 5331-5339.
[8] Bernardo, M.E., Zaffaroni, N. and Novara, F. (2007) Human Bone Marrow Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-Term in Vitro Culture and Do Not Exhibit Telomere Maintenance Mechanisms. Cancer Research, 67, 9142-9149.
[9] Zhang, Z.X., Guan, L.X., Zhang, K., Wang, S., Cao, P.C., Wang, Y.H., Wang, Z. and Dai, L.J. (2007) Cytogenetic Analysis of Human Bone Marrow-Derived Mesenchymal Stem Cells Passaged in Vitro. Cell Biology International, 31, 645-648.
[10] Mukhopadhyay, A. (2013) Perspective on Liver Regeneration by Bone Marrow-Derived Stem Cells: A Scientific Realization or a Paradox. Cytotherapy, 15, 881-892.
[11] Kochat, V., Baligar, P., Maiwall, R. and Mukhopadhyay, A. (2014) Bone Marrow Stem-Cell Therapy for Genetic and Chronic Liver Diseases. Hepatology International, 8, 166-178.
[12] Alhadlaq, A. and Mao, J.J. (2004) Mesenchymal Stem Cells: Isolation and Therapeutics. Stem Cells and Development, 13, 436-448.
[13] Rochefort, G.Y., Vaudin, P., Bonnet, N., Pages, J.C., Domenech, J., Charbord, P. and Eder, V. (2005) Influence of Hypoxia on the Domiciliation of Mesenchymal Stem Cells after Infusion into Rats: Possibilities of Targeting Pulmonary Artery Remodeling via Cells Therapies. Respiratory Research, 6, 125.
[14] Gordon, M.Y., Levicar, N., Pai, M., Bachellier, P., Dimarakis, I., Al-Allaf, F., et al. (2006) Characterization and Clinical Application of Human CD34+ Stem/Progenitor Cell Population Mobilized into the Blood by Granulocyte Colony-Stimulating Factor. Stem Cells, 24, 1822-1830.
[15] Zhao, D.C., Lei, J.X., Chen, R., Yu, W.H., Zhang, X.M., Li, S.N. and Xiang, P. (2005) Bone Marrow-Derived Mesenchymal Stem Cells Protect against Experimental Liver Fibrosis in Rats. World Journal of Gastroenterology, 11, 3431-3440.
[16] Zhao, W., Li, J.J., Cao, D.Y., Li, X., Zhang, L.Y., He, Y., Yue, S.Q., Wang, D.S. and Dou, K.F. (2012) Intravenous Injection of Mesenchymal Stem Cells Is Effective in Treating Liver Fibrosis. World Journal of Gastroenterology, 18, 1048-1058.
[17] Di Campli, C., Piscaglia, A.C., Pierelli, L., Rutella, S., Bonanno, G., Alison, M.R., Pola, P., Leone, G., Gasbarrini, G. and Gasbarrini, A. (2004) A Human Umbilical Cord Stem Cell Rescue Therapy in a Murine Model of Toxic Liver Injury. Digestive and Liver Disease, 36, 603-613.
[18] Brusick, D. (1980) Principles of Genetic Toxicology. Plenum Press, New York, 33,34,237.
[19] Natarajan, A.T., Tucker, J.D. and Sasaki, M.S. (1994) Bone Marrow Stem-Cell Therapy for Genetic and Chronic Liver Diseases. Methods to Assess DNA Damage and Repair, 95-116.
[20] Abdou, H.S., Salah, S.H., Hoda Booles, F. and Abdel Rahim, E.A. (2012) Antioxidant Effect of Celery against Carbon Tetrachloride Induced Hepatic Damage in Rats. African Journal of Microbiology Research, 6, 5657-5667.
[21] Wang, Y., Huso, D.L., Harrington, J., Kellner, J., Jeong, D.K., Turney, J. and McNiece, I.K. (2005) Outgrowth of a Transformed Cell Population Derived from Normal Human BM Mesenchymal Stem Cell Culture. Cytotherapy, 7, 509-519.
[22] Meza-Zepeda, L.A., Noer, A., Dahl, J.A., Micci, F., Myklebost, O. and Collas, P. (2008) High Resolution Analysis of Genetic Stability of Human Adipose Tissue Stem Cell Cultured to Senescence. Journal of Cellular and Molecular Medicine, 12, 553-563.
[23] Fausto, N. (2004) Liver Regeneration and Repair: Hepatocytes, Progenitor Cells, and Stem Cells. Hepatology, 39, 1477-1487.
[24] Vassilopoulos, G. and Russell, D.W. (2003) Cell Fusion: An Alternative to Stem Cell Plasticity and Its Therapeutic Implications. Current Opinion in Genetics & Development, 13, 480-485.
[25] Wang, X.L., Ge, S.D., McNamara, G., Hao, Q.L., Crooks, G.M. and Nolta, J.A. (2003) Albumin Expressing Hepatocyte-Like Cells Develop in the Livers of Immune Deficient Mice that Received Transplant of Highly Purified HSC. Blood, 101, 4201-4208.
[26] Lagasse, E., Connors, H., Al-Dhalimy, M., Reitsma, M., Dohse, M., Osborne, L. and Wang, X. (2000) Purified Hematopoietic Stem Cells Can Differentiate into Hepatocytes in Vivo. Nature Medicine, 6, 1229-1234.
[27] Jang, Y.Y., Collector, M.I., Baylin, S.B., Diehl, A.M. and Sharkis, S.J. (2004) Hematopoietic Stem Cells Convert into Liver Cells within Days without Fusion. Nature Cell Biology, 6, 532-539.
[28] Sharma, A.D., Cantz, T., Richter, R., Eckert, K., Henschler, R., Wilkens, L., Jochheim-Richter, A., Arseniev, L. and Ott, M. (2005) Human Cord Blood Stem Cells Generate Human Cytokeratin 18-Negative Hepatocyte-Like Cells in Injured Mouse Liver. American Journal of Pathology, 167, 555-564.
[29] Kogler, G., Sensken, S., Airey, J.A., Trapp, T., Muschen, M., Feldhahn, N., Liedtke, S., et al. (2004) A New Human Somatic Stem Cell from Placental Cord Blood with Intrinsic Pluripotent Differentiation Potential. Journal of Experimental Medicine, 200, 123-135.
[30] Ishikawa, F., Drake, C.J., Yang, S., Fleming, P., Visconti, R.P., Harada, M., Ogawa, M., et al. (2003) Transplanted Human Cord Blood Cells Give Rise to Hepatocytes in Engrafted Mice. Annals of the New York Academy of Sciences, 996, 174-185.
[31] Kakinuma, S., Tanaka, Y., Chinzel, R., Watanabe, M., Shimizu-saito, K., Hara, Y., et al. (2003) Human Umbilical Cord Blood as a Source of Transplantable Hepatic Progenitor Cells. Stem Cells, 21, 217-227.
[32] Nonome, K., Li, X.K., Takahara, T., Kitazawa, Y., Funeshima, N., Yata, Y., Xue, F., Kanayama, M., Shinno, E., Kuwae, C., Watanabe, A. and Sugiyama, T. (2005) Human Umbilical Cord Blood-Derived Cells Differentiate into Hepatocyte-Like Cells in the Fas-Mediated Liver Injury Model. American Journal of Physiology-Gastrointestinal and Liver Physiology, 289, G1091-G1099.

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.